PTGX: Protagonist Therapeutics, Inc. Stock

by  •  • Comments Off on PTGX: Protagonist Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2,727.92
Enterprise Value ($M) 2,630.67
Book Value ($M) 675.29
Book Value / Share 11.00
Price / Book 4.04
NCAV ($M) 522.21
NCAV / Share 8.51
Price / NCAV 5.22

Profitability (mra)
Return on Invested Capital (ROIC) 0.40
Return on Assets (ROA) 0.44
Return on Equity (ROE) 0.49

Liquidity (mrq)
Quick Ratio 12.48
Current Ratio 12.48

Balance Sheet (mrq) ($M)
Current Assets 591.64
Assets 744.73
Liabilities 69.43
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 434.43
Operating Income 252.84
Net Income 275.19
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 184.15
Cash from Investing -299.48
Cash from Financing 25.85

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-10 13G/A Farallon Capital Partners, L.P. 9.99 3.32
02-05 13G/A BlackRock, Inc. 16.60 -7.31
11-14 13G/A Biotechnology Value Fund L P 4.90 -48.47
11-12 13G/A Vanguard Group Inc 7.15 0.00
10-16 13G State Street Corp 5.40 16.62

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-07 308,878 1,303,658 23.69
2025-04-04 504,698 1,543,258 32.70
2025-04-03 280,201 1,125,869 24.89
2025-04-02 294,535 1,035,855 28.43

(click for more detail)

Similar Companies
OKUR – OnKure Therapeutics, Inc. OMER – Omeros Corporation
PAHC – Phibro Animal Health Corporation RANI – Rani Therapeutics Holdings, Inc.
RAPT – RAPT Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io